About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Entitlement Offer Raises Over AUD3M

October 25, 2017

Click here to read more

Post navigation

Extension of Closing Date of Entitlement Offer

Phosphagenics Mylan Arbitration Hearing Concluded

Related Posts

Phosphagenics Initiates Cattle Study

June 1, 2016

Phosphagenics Participation in ‘New Innovations in Drug Delivery Technology’ Webcast

April 12, 2017

Phosphagenics TPM Improves Negative Effects of Heat Stress in Poultry

December 15, 2017

Recent Posts

First Patient Dosed in Phase III Insomnia Trial
May 16, 2024
MEDIA | Channel 9 News
March 28, 2024
Avecho’s Phase III Clinical Trial for Insomnia Commences
March 26, 2024

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.